|
1
|
Cangır AK, Yumuk PF, Sak SD, Akyürek S, Eralp Y, Yılmaz Ü, Selek U, Eroğlu A, Tatlı AM, Dinçbaş FÖ, Kılıçkap S, Şendur MAN, Dilektaşlı AG, Bozcuk HŞ, Özkök S, Öztop İ, Topkan E, Dilege Ş, Kaya A, Demirkazık A. Lung Cancer in Turkey. J Thorac Oncol 2022; 17:1158-1170. [PMID: 36192076 DOI: 10.1016/j.jtho.2022.06.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Accepted: 06/01/2022] [Indexed: 11/21/2022]
Affiliation(s)
- Ayten Kayı Cangır
- Department of Thoracic Surgery, Ankara University Faculty of Medicine and Ankara University Medical Design Application and Research Center (MEDITAM), Ankara, Turkey.
| | - Perran Fulden Yumuk
- Division of Medical Oncology, Department of Internal Medicine, Koç University School of Medicine, İstanbul, Turkey
| | - Serpil Dizbay Sak
- Department of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey
| | - Serap Akyürek
- Department of Radiation Oncology, Ankara University Faculty of Medicine, Ankara, Turkey
| | - Yeşim Eralp
- Department of Medical Oncology, Acıbadem University, Maslak Acıbadem Hospital, İstanbul, Turkey
| | - Ülkü Yılmaz
- Department of Pulmonology, Health Science University, Atatürk Sanatoryum Training and Education Hospital, Ankara, Turkey
| | - Uğur Selek
- Department of Radiation Oncology, Koç University, School of Medicine, İstanbul, Turkey; Department of Radiation Oncology, İstanbul University, Cerrahpaşa School of Medicine, İstanbul, Turkey
| | - Atilla Eroğlu
- Department of Thoracic Surgery, Atatürk University, School of Medicine, Erzurum, Turkey
| | - Ali Murat Tatlı
- Department of Internal Medicine, Division of Medical Oncology, Akdeniz University, School of Medicine, Antalya, Turkey
| | - Fazilet Öner Dinçbaş
- Department of Radiation Oncology, İstanbul University, Cerrahpaşa School of Medicine, İstanbul, Turkey
| | - Saadettin Kılıçkap
- Department of Internal Medicine, İstinye University Faculty of Medicine, İstanbul, Turkey; Division of Medical Oncology, Private Liv Hospital, Ankara, Turkey
| | - Mehmet Ali Nahit Şendur
- Department of Medical Oncology, Ankara Yıldırım Beyazıt University Faculty of Medicine and Ankara City Hospital, Ankara, Turkey
| | | | - Hakan Şat Bozcuk
- Department of Medical Oncology, Medical Park Antalya Hospital, Antalya, Turkey
| | - Serdar Özkök
- Department of Radiation Oncology, Ege University School of Medicine, İzmir, Turkey
| | - İlhan Öztop
- Department of Medical Oncology, Dokuz Eylül University, Oncology Institute, İzmir, Turkey
| | - Erkan Topkan
- Department of Radiation Oncology, Başkent University School of Medicine, Adana, Turkey
| | - Şükrü Dilege
- Department of Thoracic Surgery, Koç University, School of Medicine, İstanbul, Turkey
| | - Akın Kaya
- Department of Pulmonology, Ankara University Faculty of Medicine, Ankara, Turkey
| | - Ahmet Demirkazık
- Division of Medical Oncology, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Turkey
| |
Collapse
|
|
2
|
Hizal M, Bilgin B, Paksoy N, Kılıçkap S, Atcı MM, Kahraman S, Keskinkılıç M, Bilgetekin İ, Ayhan M, Tural D, Eren Ö, Akkoç Mustafayev FN, Yaman Ş, Tatlı AM, Bayram E, Kutlu Y, Ertürk İ, Özcan E, Gülmez A, Korkmaz M, Akagündüz B, Erdem D, Telli TA, Aksoy A, Üskent N, İriağaç Y, Baytemür NK, Aydın D, Şakalar T, Arak H, Selçukbiricik F, Ergün Y, Korkmaz T, Ak N, Ünal Ç, Akdeniz N, Özgün MA, Öksüzoğlu B, Yalçın B, Öztop İ, Algın E, Sakin A, Aydıner A, Yumuk PF, Nahit Şendur MA. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol 2022; 18:2573-2582. [PMID: 35734870 DOI: 10.2217/fon-2022-0083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Aims: In this multicenter study, the authors aimed to determine the real-life efficacy and safety of first-line alectinib. Materials & methods: This retrospective trial included advanced-stage, ALK-positive non-small-cell lung cancer patients who were treated with first-line alectinib in terms of ALK-tyrosine kinase inhibitors, regardless of previous chemotherapy. The co-primary end points were progression-free survival both for all patients and for the treatment-naive population. The secondary end points were overall response rate, overall survival, rate of CNS progression and safety. Results & conclusion: A total of 274 patients (n = 177 for treatment-naive patients) were enrolled in the study. The median progression-free survival was 26 and 28.8 months for all patients and the treatment-naive group, respectively. The overall response rate, CNS progression rate and 1-year overall survival ratio were 77.9, 12.4 and 77%. Alectinib is a highly effective therapy with a favorable safety profile.
Collapse
Affiliation(s)
- Mutlu Hizal
- Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey
| | - Burak Bilgin
- Atatürk Chest Disease & Chest Surgery Education & Research Hospital, Department of Medical Oncology, Ankara, Turkey
| | - Nail Paksoy
- Department of Medical Oncology, İstanbul Faculty of Medicine, İstanbul University, Istanbul, Turkey
| | - Saadettin Kılıçkap
- Department of Medical Oncology, İstinye University Faculty of Medicine, Ankara Liv Hospital, Ankara, Turkey
| | - Muhammed Mustafa Atcı
- Department of Medical Oncology, İstanbul Prof. Cemil Taşçıoglu City Hospital, Istanbul, Turkey
| | - Seda Kahraman
- Department of Medical Oncology, Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey
| | - Merve Keskinkılıç
- Department of Medical Oncology, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey
| | - İrem Bilgetekin
- Department of Medical Oncology, Abdurrahman Yurtaslan Ankara Onkoloji Education & Research Hospital, Ankara, Turkey
| | - Murat Ayhan
- Department of Medical Oncology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey
| | - Deniz Tural
- Department of Medical Oncology, Bakırköy Dr. Sadi Konuk Education & Research Hospital, Istanbul, Turkey
| | - Önder Eren
- Department of Medical Oncology, Selçuk University Faculty of Medicine, Konya, Turkey
| | - Fatma Nihan Akkoç Mustafayev
- Department of Medical Oncology, University of Health Sciences, Sultan 2. Abdülhamid Han Education & Research Hospital, Istanbul, Turkey
| | - Şebnem Yaman
- Atatürk Chest Disease & Chest Surgery Education & Research Hospital, Department of Medical Oncology, Ankara, Turkey
| | - Ali Murat Tatlı
- Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey
| | - Ertuğrul Bayram
- Department of Medical Oncology, Çukurova University Faculty of Medicine, Adana, Turkey
| | - Yasin Kutlu
- Department of Medical Oncology, İstanbul Medipol University Faculty of Medicine, Istanbul, Turkey
| | - İsmail Ertürk
- Department of Medical Oncology, Ankara Gülhane Education & Research Hospital, Ankara, Turkey
| | - Erkan Özcan
- Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey
| | - Ahmet Gülmez
- Department of Medical Oncology, İnönü University Faculty of Medicine, Malatya, Turkey
| | - Mustafa Korkmaz
- Department of Medical Oncology, Necmettin Erbakan University, Meram Faculty of Medicine, Konya, Turkey
| | - Baran Akagündüz
- Department of Medical Oncology, Erzincan Mengücek Gazi Education & Research Hospital, Erzincan, Turkey
| | - Dilek Erdem
- Department of Medical Oncology, Samsun Medical Park Hospital, Samsun, Turkey
| | - Tuğba Akın Telli
- Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey
| | - Asude Aksoy
- Department of Medical Oncology, Fırat University Faculty of Medicine, Elazıg, Turkey
| | - Necdet Üskent
- Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey
| | - Yakup İriağaç
- Department of Medical Oncology, Tekirdağ Namık Kemal University Faculty of Medicine, Tekirdag, Turkey
| | | | - Dinçer Aydın
- Department of Medical Oncology, Kocaeli Derince Education & Research Hospital, Kocaeli, Turkey
| | - Teoman Şakalar
- Department of Medical Oncology, Necip Fazıl City Hospital, Kahramanmaras, Turkey
| | - Hacı Arak
- Gaziantep University Faculty of Medicine, Department of Medical Oncology, Gaziantep, Turkey
| | - Fatih Selçukbiricik
- Department of Medical Oncology, Koç University Faculty of Medicine, Istanbul, Turkey
| | - Yakup Ergün
- Department of Medical Oncology, Batman Education & Research Hospital, Batman, Turkey
| | - Taner Korkmaz
- Department of Medical Oncology, Acıbadem Maslak Hospital, Istanbul, Turkey
| | - Naziye Ak
- Department of Medical Oncology, Yozgat City Hospital, Yozgat, Turkey
| | - Çağlar Ünal
- Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey
| | - Nadiye Akdeniz
- Department of Medical Oncology, Adıyaman University, Education & Research Hospital, Adıyaman, Turkey
| | - Mehmet Alpaslan Özgün
- Department of Medical Oncology, University of Health Sciences, Sultan 2. Abdülhamid Han Education & Research Hospital, Istanbul, Turkey
| | - Berna Öksüzoğlu
- Department of Medical Oncology, Abdurrahman Yurtaslan Ankara Onkoloji Education & Research Hospital, Ankara, Turkey
| | - Bülent Yalçın
- Department of Medical Oncology, Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey
| | - İlhan Öztop
- Department of Medical Oncology, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey
| | - Efnan Algın
- Department of Medical Oncology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey
| | - Abdullah Sakin
- Department of Medical Oncology, İstanbul Prof. Cemil Taşçıoglu City Hospital, Istanbul, Turkey
| | - Adnan Aydıner
- Department of Medical Oncology, İstanbul Faculty of Medicine, İstanbul University, Istanbul, Turkey
| | - Perran Fulden Yumuk
- Department of Medical Oncology, Koç University Faculty of Medicine, Istanbul, Turkey.,Department of Medical Oncology, American Hospital, Istanbul, Turkey
| | - Mehmet Ali Nahit Şendur
- Department of Medical Oncology, Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey
| |
Collapse
|